Where does Creganna Unlimited Company rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Creganna Unlimited Company ranks #16,710 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Creganna Unlimited Company hold?

Creganna Unlimited Company holds 17 US utility patents granted between 2018 and 2025, spanning 16 technology areas.

What is Creganna Unlimited Company's Innovation Score?

Creganna Unlimited Company has an Innovation Score of 41.4 out of 100 (top 33% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Creganna Unlimited Company's patent grant rate increasing or decreasing?

Creganna Unlimited Company's recent grant velocity is +67% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Creganna Unlimited Company's patents?

Creganna Unlimited Company's patents average 14.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Creganna Unlimited Company patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Creganna Unlimited Company

Q: What technology areas does Creganna Unlimited Company focus on?

Creganna Unlimited Company's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 12 patents, ranking #592 of 3,490 assignees active in that subclass. Grants appear in 16 CPC subclasses total.

USPTO PatentsView assignee record - 17 granted patents across 16 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Creganna ranks #16,710 of 49,997 tracked US assignees by granted-patent volume, with 17 patents across 16 technology areas.

#16,710
of 49,997 US assignees by volume: Top 33%
by Innovation Score (41.4/100): 14.0
avg claims per patent: +67%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R16710 · Foreign Corporation #16,710 · 17 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 17 grants
MID-PACK #16,710/49,997
PHOTO-FINISH ContiTech Vibration…
CPC-FOCUS A61M · 16 areas
INNOV-PAR 41.4/100
CLAIMS-RICH 14.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +67% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: ContiTech Vibration Control GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Creganna’s 41.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.0 pts (24%) Velocity 8.9 pts (21%) Breadth 14.1 pts (34%) Claim depth 8.4 pts (20%)

Qualcomm Incorporated · highest

85
Creganna Unlimited · this assignee

41
3D Lighting… · lowest

7

What this shows Creganna's Innovation Score is 41.4/100 (top 33% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Creganna?

Each dot is one of Creganna’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Creganna’s own 14.0 claims/patent is ABOVE the 13.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Creganna vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Creganna's grants concentrate

Creganna Unlimited Company is a focused PatentsView assignee: 16 CPC subclasses with 70.6% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2019 (4 grants) versus a trough of 1 in 2020. By volume, Creganna sits between ContiTech Vibration Control GmbH and Cyemptive Technologies, Inc..

Creganna's three-year grant acceleration

Creganna Unlimited Company shows 8 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Contitech Vibrati…

17
Coreline Soft

17
Country Casual Te…

17
Crackle

17
Critical Innovati…

17
Crucell Holland B…

17
Custom Medical Ap…

17
Cyemptive

17
Creganna Unlimited ◀

17

What this shows Creganna holds 17 patents at rank #16,715, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Creganna

By rank, the assignees closest to #16,715 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Creganna's primary technology class.

Creganna's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 33% higher than 67% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Creganna Unlimited Company patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	2	11.8%
2019	4	23.5%
2020	1	5.9%
2021	1	5.9%
2022	2	11.8%
2023	3	17.6%
2024	3	17.6%
2025partial year	1	5.9%

Which technologies does Creganna Unlimited Company patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 12

A61B - DIAGNOSIS; SURGERY; Identification 6

H01B - CABLES; CONDUCTORS; INSULATORS; Selection OF Materials FOR Their Conductive, Insulating OR Dielectric Properties 4

Y10T - Technical Subjects Covered BY Former US Classification 2

B33Y - Additive Manufacturing, i.e. Manufacturing OF Three-dimensional [3-D] Objects BY Additive Deposition, Additive Agglomeration OR Additive Layering, e.g. BY 3-D Printing, Stereolithography OR Selective Laser Sintering 2

H04N - Pictorial Communication, e.g. Television 1

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

B29D - Producing Particular Articles From Plastics OR From Substances IN A Plastic State 1

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 1

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 1

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 1

C08L - Compositions OF Macromolecular Compounds 1

H01R - Electrically-conductive CONNECTIONS; Structural Associations OF A Plurality OF Mutually-insulated Electrical Connecting ELEMENTS; Coupling DEVICES; Current Collectors 1

Top 15 of 16 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Creganna Unlimited Company's patent record in context - here's where to go next.

Creganna Unlimited Company's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 70.6% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #16,710 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Creganna Unlimited Company against ContiTech Vibration Control GmbH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.